Video Experimental Relacionado
Updated: Jan 7, 2026

08:56
Development of New Therapeutic Applications Using Microfluidics
Published on: October 1, 2007
5.7K
Desarrollo farmacéutico impulsado por la innovación y avance clínico
1Center for Immunotherapy, Chinese Academy of Medical Sciences, Beijing 100005, China.
Zhonghua yi xue za zhi
|December 25, 2025
Resumen
China
Área de la Ciencia:
- Desarrollo farmacéutico
- Tecnología biomédica
- Avance clínico
Sus antecedentes:
- China ha logrado una posición de liderazgo mundial en el desarrollo de fármacos innovadores y acuerdos de licencia.
- Este progreso se atribuye a la innovación en tecnología biomédica, el apoyo de políticas, la aceleración de los procesos regulatorios y las reformas del sistema de pagos.
Objetivo del estudio:
- Analizar sistemáticamente el progreso, los desafíos y las direcciones futuras del desarrollo de fármacos innovadores en China.
- Destacar los desafíos clave, los puntos críticos actuales y los posibles avances en el desarrollo farmacéutico.
- Esbozar las direcciones prioritarias para integrar el desarrollo farmacéutico con la práctica médica.
Principales métodos:
- Análisis sistemático del panorama del desarrollo de fármacos innovadores en China.
- Revisión de los desafíos actuales, incluida la capacidad de innovación original y la alineación clínica.
- Examen de las iniciativas políticas y las direcciones estratégicas futuras.
Principales resultados:
- China ocupa el primer lugar a nivel mundial en el desarrollo de fármacos innovadores y acuerdos de licencia.
- Los desafíos persistentes incluyen la débil capacidad de innovación original, la desalineación con las necesidades clínicas y la limitada participación internacional.
- Un nuevo proyecto nacional se centra en el desarrollo de capacidades, la innovación original y los ecosistemas colaborativos.
Conclusiones:
- China tiene como objetivo establecer un sistema de innovación de fármacos independiente y líder a nivel mundial para 2035.
- Abordar los desafíos actuales es crucial para el crecimiento sostenido y el apoyo a la iniciativa 'Salud China'.
- Fomentar una integración más profunda entre el desarrollo de fármacos y la práctica clínica es una prioridad clave.
Palabras clave:
Desarrollo de fármacosChinaHumanosDescubrimiento de fármacosIndustria farmacéuticaTecnología biomédicaMás Videos Relacionados
Videos de Conceptos Relacionados
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Biopharmaceutical Factors Influencing Drug Product Design: Overview
217
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
217

